Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-043008
Filing Date
2023-07-20
Accepted
2023-07-20 21:48:01
Documents
2
Period of Report
2023-07-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5120
2 POA DOCUMENT poa.txt EX-24 3983
  Complete submission text file 0001209191-23-043008.txt   10503
Mailing Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010
Business Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010 347-897-5988
Turnstone Biologics Corp. (Issuer) CIK: 0001764974 (see all company filings)

EIN.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SYNLOGIC, INC. 301 BINNEY STREET, SUITE 402 CAMRIDGE MA 02142
Business Address
Burgess Michael F. (Reporting) CIK: 0001801745 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41747 | Film No.: 231100977